Dr. Joseph William Shelton, MD

Dr. Shelton practices at Sentara Martha Jefferson Hospital in Charlottesville, Virginia, part of Sentara Health.

Dr. Shelton's NPI, 1093990350, was assigned on January 7, 2008. Dr. Shelton graduated from University of North Carolina at Chapel Hill School of Medicine in 2006. Dr. Shelton holds Georgia license 002268.

Dr. Shelton's primary practice is Sentara Martha Jefferson Hospital, at 500 Martha Jefferson Drive, Charlottesville, VA 22911 in Albemarle County. The practice phone is (434) 654-7000.

Dr. Shelton's primary practice is Sentara Martha Jefferson Hospital in Charlottesville, Virginia, part of Sentara Health. Dr. Shelton is also affiliated with University Medical Center. The medical group on file is Emory Clinic. Dmand AI also links Dr. Shelton to 3 more hospitals, 3 medical groups, 1 group practice or clinic, 1 hospital outpatient department and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shelton practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shelton's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shelton is licensed in Georgia.

CMS data shows 579 Medicare services from Dr. Shelton across 11 procedure codes in 2024, for 77 Medicare patients. Medicare paid $54,082 for them.

CMS counts 77 Medicare patients who saw Dr. Shelton in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have cancer, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shelton's median patient age at 69, with 44% women.

In 2024, Dr. Shelton wrote 99 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $184 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Shelton for performance year 2024, reported through an alternative payment model (APM). Dr. Shelton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 44 papers to Dr. Shelton, published from 2012 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Lung Neoplasms and Radiotherapy, Image-Guided. Dr. Shelton has published most often in Int J Radiat Oncol Biol Phys. Dr. Shelton's most frequent co-authors are Ashesh B. Jani, MD, Peter Justin Rossi, MD, PhD and Tony Y. Eng, MD.

Dmand AI links Dr. Shelton to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Cognitive Dysfunction, Urinary Bladder Neoplasms and Uterine Cervical Neoplasms.

CMS Open Payments shows 51 general payments to Dr. Shelton from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Varian Medical Systems, Inc. paid the most, $4,457.

Dr. Shelton graduated from University of North Carolina at Chapel Hill School of Medicine in 2006.